Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

Subjects:

Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Patients’ histories are presented in decreasing length of observation and colour coded as red for the days of use or referred use and green for abstinence days. by Francesco Lolli (2530471)

Subjects:

Negativity ratings (mean ± SE) during <i>attend/negative</i> trials (left) and <i>decrease/negative</i> trials (right) of the emotion regulation task, in the TSD (red) and WR (blue... by Anthony R. Stenson (11378981)

Current health gap scorecard: American countries. by Fabrício Silveira (12902492)

“…<p>Notes: Indicators 3.b.1a,b,c and 17.19.2 omitted due to the lack of statistical significance of the estimations. The gap index was adjusted to indicate improvement upwards and worsening downwards regardless of the direction of improvement of the indicator. …”

Catalytic fold of WT PARG1 C1-GAP domain for RhoA interaction. by Zen Kouchi (14898435)

Baseline characteristics of women by randomization method^$ (mITT analysis). by Chanel Avenant (409756)

Subjects:

Trial profile. by Chanel Avenant (409756)

Subjects:

Mean percentage changes (95% CI) in total testosterone, SHBG and free testosterone (mITT analysis). by Chanel Avenant (409756)

Subjects:

Pairwise comparisons of hormonal results for DMPA-IM vs NET-EN expressed as mean percentage differences (95% CI) (mITT analysis). by Chanel Avenant (409756)

Subjects:

Total testosterone (nmol/L), SHBG (nmol/L) and free testosterone (pmol/L) outcomes at baseline and 25 weeks (mITT analysis). by Chanel Avenant (409756)

Subjects:

Total testosterone (nmol/L), SHBG (nmol/L) and free testosterone (nmol/L), outcomes at baseline and 25 weeks (mITT analysis). by Chanel Avenant (409756)

Subjects:

Pelvic ring injury in the elderly: Fragile patients with substantial mortality rates and long-term physical impairment by Hester Banierink (6743714)

“…Overall, physical functioning and quality of life were significantly decreased in comparison with normative data from the general population.…”

Summary statistics for sharing data. by Sandra Weltzien (4752198)

Subjects:

Frequency distribution of donations across populations and conditions. by Sandra Weltzien (4752198)

Subjects:

Mean percentage of stickers shared as a function of prime type. by Sandra Weltzien (4752198)

Subjects:

Raw data. by Sandra Weltzien (4752198)

Subjects:

FGF18 injections increase TIMP1 and decrease MMP13 and NOGGIN, suggesting healing of degeneration induction of anabolic effect. by Flavia Gomes Velasque Gama (21175112)